mRNA-4157,Pembrolizumab
Moderna,Merck
['key,note,42', 'mrna-4157', 'key,note,57', 'keynote,942', 'melanoma', 'pembro']
according to results from the keynote-942 trial, adding the personalized mrna cancer vaccine mrna-4157/v940 to pembrolizumab may prolong recurrence-free survival in patients with high-risk melanoma. #aacr23
The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.